GENEVA, Nov. 1, 2016 /PRNewswire/ -- Today, High Lantern Group (www.highlanterngroup.com) announced that Mario Ottiglio has joined the firm as a Managing Director based in Geneva, Switzerland. Through establishing a presence in Europe, High Lantern Group expands its footprint to meet clients' global needs.
"We are expanding to meet the increasing international needs of businesses, global institutions and trade associations to compete more effectively in their markets, better engage in thought leadership and positively shape the external environment in which they operate," said Michael W. Hodin, Ph.D., Managing Partner at High Lantern Group. "I am confident that Mario's expertise and proven professional achievements, especially in the pharmaceutical, healthcare and life sciences sectors, will be a huge benefit to our existing clients and provide the foundation for serving a growing global client base. Moreover, our unique expertise through the Global Coalition on Aging (www.globalcoalitiononaging.com) will gain further leverage through our new presence in Geneva."
This is the first expansion of High Lantern Group outside the United States where it currently has offices in New York City, Washington D.C., Los Angeles, Philadelphia, PA, and Asheville, NC. It will bolster the firm's existing connections to European-based corporations, international organizations, trade associations, and influencers, and promote accelerated outreach and collaboration with new partners. The new Geneva office will also serve as a springboard to meet the needs of clients based in other key hubs across Europe and Asia, who can benefit from High Lantern Group's expertise in public affairs, communications, and reputation as powerful drivers of business development, corporate value enhancement and stakeholder relationships.
"Based on my experience in the international pharmaceutical industry, working to create synergies across public and private sectors, I recognized that High Lantern Group brings a unique approach to success in an ever-changing business landscape," said Ottiglio, who has held leadership roles at international health organizations for more than a decade. Previously he served as the Director of Public Affairs, Communications & Global Health Policy at the International Federation of Pharmaceutical Manufacturers and prior to that worked in governmental institutions and private firms. "Operating out of a key world public affairs hub, High Lantern Group will take clients on a journey through the lifecycle of ideas and initiatives, from early-stage strategy, to engagement and implementation."
High Lantern Group is a strategic consulting firm focused at the intersection of business strategy, public policy and reputation. The firm develops strategies for influence and thought leadership in the public arena focusing on global health, life sciences, financial services, and retail, among others. For more information, please visit www.highlanterngroup.com.
SOURCE High Lantern Group